JP2024527715A - イメージング用医薬組成物 - Google Patents
イメージング用医薬組成物 Download PDFInfo
- Publication number
- JP2024527715A JP2024527715A JP2023580416A JP2023580416A JP2024527715A JP 2024527715 A JP2024527715 A JP 2024527715A JP 2023580416 A JP2023580416 A JP 2023580416A JP 2023580416 A JP2023580416 A JP 2023580416A JP 2024527715 A JP2024527715 A JP 2024527715A
- Authority
- JP
- Japan
- Prior art keywords
- pdexacyaninium
- free form
- pharmaceutical composition
- pudexacyaninium
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
- A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163226534P | 2021-07-28 | 2021-07-28 | |
| US63/226,534 | 2021-07-28 | ||
| PCT/IB2022/056957 WO2023007404A1 (en) | 2021-07-28 | 2022-07-27 | Pudexacianinium for nirf imaging |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527715A true JP2024527715A (ja) | 2024-07-26 |
| JP2024527715A5 JP2024527715A5 (cg-RX-API-DMAC7.html) | 2025-05-21 |
Family
ID=82898903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023580416A Pending JP2024527715A (ja) | 2021-07-28 | 2022-07-27 | イメージング用医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240342316A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4376896A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024527715A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240041952A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117715661A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022321011A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3226034A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024001242A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023007404A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024084287A1 (en) * | 2022-10-21 | 2024-04-25 | Astellas Pharma Inc. | Composition for near infrared lymphatic imaging and uses and dosages therefor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9056131B2 (en) | 2010-01-28 | 2015-06-16 | National University Corporation Mie University | Indocyanine compound, synthesis method and purification method thereof, diagnostic composition using the indocyanine compound, and device for measuring biokinetics and device for visualizing circulation using the diagnostic composition |
-
2022
- 2022-07-27 JP JP2023580416A patent/JP2024527715A/ja active Pending
- 2022-07-27 AU AU2022321011A patent/AU2022321011A1/en active Pending
- 2022-07-27 US US18/291,487 patent/US20240342316A1/en active Pending
- 2022-07-27 EP EP22754545.6A patent/EP4376896A1/en active Pending
- 2022-07-27 WO PCT/IB2022/056957 patent/WO2023007404A1/en not_active Ceased
- 2022-07-27 CN CN202280052692.7A patent/CN117715661A/zh active Pending
- 2022-07-27 CA CA3226034A patent/CA3226034A1/en active Pending
- 2022-07-27 KR KR1020247005443A patent/KR20240041952A/ko active Pending
- 2022-07-27 MX MX2024001242A patent/MX2024001242A/es unknown
Non-Patent Citations (3)
| Title |
|---|
| MOL. IMAGING BIOL., JPN6026032558, 2021, ISSN: 0005920758 * |
| MOL. IMAGING BIOL., vol. 25, JPN6026032557, May 2021 (2021-05-01), pages 74 - 84, ISSN: 0005920756 * |
| 米国FDA, GUIDANCE FOR INDUSTRY, JPN6012064675, July 2005 (2005-07-01), ISSN: 0005920757 * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240041952A (ko) | 2024-04-01 |
| EP4376896A1 (en) | 2024-06-05 |
| AU2022321011A1 (en) | 2024-01-25 |
| WO2023007404A1 (en) | 2023-02-02 |
| CN117715661A (zh) | 2024-03-15 |
| MX2024001242A (es) | 2024-02-13 |
| CA3226034A1 (en) | 2023-02-02 |
| US20240342316A1 (en) | 2024-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | In vivo MR and fluorescence dual-modality imaging of atherosclerosis characteristics in mice using profilin-1 targeted magnetic nanoparticles | |
| Li et al. | Mesencephalic astrocyte‐derived neurotrophic factor affords neuroprotection to early brain injury induced by subarachnoid hemorrhage via activating Akt‐dependent prosurvival pathway and defending blood‐brain barrier integrity | |
| JP5908527B2 (ja) | 慢性虚血における亜硝酸塩の使用 | |
| CN110267644B (zh) | 用于治疗腺样囊性癌的苯磺酰胺衍生物的医药组合物 | |
| Murase et al. | Randomized, double‐blind, controlled study to evaluate safety and pharmacokinetics of single ascending doses of ASP5354, an investigational imaging product, in healthy adult volunteers | |
| KR20180055877A (ko) | 허혈성 조직으로 구리를 운반하기 위한 트리엔틴의 용도 | |
| EP3154551B1 (en) | The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject | |
| JP5211073B2 (ja) | 子宮内膜症の治療用の薬剤 | |
| TW201121992A (en) | Suppression of cancer metastasis | |
| US20240342316A1 (en) | A pharmaceutical composition for imaging | |
| WO2024193321A1 (zh) | Glyt1抑制剂在治疗器官纤维化中的应用 | |
| Wang et al. | Self-assembled extracellular matrix-lipid nanoparticle composite for site-specific siRNA delivery to improve cardiac repair post-myocardial infarction | |
| Lin et al. | Molecular photoacoustic imaging for early diagnosis and treatment monitoring of rheumatoid arthritis in a mouse model | |
| WO2015190989A1 (en) | The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject | |
| HK40104552A (en) | Pudexacianinium for nirf imaging | |
| WO2021093376A1 (zh) | 磷酸二酯酶5抑制剂在制备抗纤维化疾病药物中的应用 | |
| TWI899198B (zh) | 包含15-hepe之組成物及治療或預防血液學病症及/或相關疾病之方法 | |
| CN110404072A (zh) | 抑制yap蛋白第357位酪氨酸残基磷酸化的物质在预防动脉粥样硬化中的应用 | |
| CN110548020B (zh) | 亚精胺在制备治疗主动脉瘤药物方面的应用 | |
| Akarsu | Hydroxychloroquine: From Pharmacological Profile to Neglected Adverse Reactions | |
| Yang et al. | Establishment of a novel rat model of different degrees of portal vein stenosis following 70% partial hepatectomy | |
| Graham | 25 Vascular Anomalies of the Head and Neck | |
| Hao et al. | Case Report: Atrial myxoma combined with hyperthyroidism in an adolescent with literature review | |
| JP6706632B2 (ja) | 半月板変性治療用組成物 | |
| CN116492447A (zh) | Foxm1在制备治疗缺血性心脏病药物中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250512 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250512 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260731 |